Rigamonti Antonello E, Bondesan Adele, Rondinelli Eugenia, Cella Silvano G, Sartorio Alessandro
Department of Clinical Sciences and Community Health, University of Milan, 20129 Milan, Italy.
Experimental Laboratory for Auxo-Endocrinological Research, IRCCS, Istituto Auxologico Italiano, 28824 Verbania, Italy.
Metabolites. 2022 Feb 8;12(2):155. doi: 10.3390/metabo12020155.
The aspartate transaminase to platelet ratio index (APRI) has been proposed as an easy-to-use biochemical marker in obese adults with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatotic hepatitis (NASH). The objective of the present study was to evaluate the clinical and predictive value of APRI in a paediatric obese population. Seven hundred fifty-seven obese children and adolescents (BMI standard deviation score, SDS: >2.0; age range: 10-18.5 years), not consuming alcohol and without hepatitis B or C, were recruited after having been screened for NAFLD by ultrasonography. A series of demographic, biochemical and clinical parameters was compared between the two subgroups (with or without NAFLD); the same parameters were correlated with APRI; and finally, univariable and multivariable logistic regression was used to evaluate the predictors of NAFLD. NAFLD was diagnosed in about 39% of the entire paediatric population, predominantly in males and in subjects suffering from metabolic syndrome. APRI was correlated with the waist circumference (WC), high-density lipoprotein cholesterol (HDL-C), uric acid, total bilirubin, C reactive protein (CRP) and systolic blood pressure (SBP). Furthermore, APRI was higher in males than females, but independent from steatosis severity and metabolic syndrome. With the univariable analysis, the BMI SDS, triglycerides (TG), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), APRI, uric acid and metabolic syndrome were positive predictors of NAFLD, with female sex being negative predictor. At multivariable analysis; however, only BMI SDS, TG, HOMA-IR and APRI were positive predictors of NAFLD, with female sex being a negative predictor. The accuracy of APRI as a biochemical marker of NAFLD was about 60%.In conclusion, in a large (Italian) paediatric obese population, parameters, such as BMI SDS, TG, HOMA-IR and APRI, were positive predictors of NAFLD, with female sex being a negative predictor and most of the prediction explained by APRI. Nevertheless, APRI appears to be a simple biochemical marker of liver injury rather than of NAFLD/NASH and, moreover, is endowed with a limited accuracy for the prediction/diagnosis of NAFLD.
天冬氨酸转氨酶与血小板比值指数(APRI)已被提议作为非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)肥胖成年人中一种易于使用的生化标志物。本研究的目的是评估APRI在儿科肥胖人群中的临床和预测价值。对757名肥胖儿童和青少年(BMI标准差评分,SDS:>2.0;年龄范围:10 - 18.5岁)进行了招募,这些儿童不饮酒且无乙型或丙型肝炎,在通过超声检查筛查NAFLD后入组。对两个亚组(有或无NAFLD)的一系列人口统计学、生化和临床参数进行了比较;将相同参数与APRI进行相关性分析;最后,使用单变量和多变量逻辑回归来评估NAFLD的预测因素。在整个儿科人群中,约39%被诊断为NAFLD,主要为男性以及患有代谢综合征的个体。APRI与腰围(WC)、高密度脂蛋白胆固醇(HDL - C)、尿酸、总胆红素、C反应蛋白(CRP)和收缩压(SBP)相关。此外,男性的APRI高于女性,但与脂肪变性严重程度和代谢综合征无关。单变量分析显示,BMI SDS、甘油三酯(TG)、胰岛素、胰岛素抵抗稳态模型评估(HOMA - IR)、APRI、尿酸和代谢综合征是NAFLD的阳性预测因素,女性为阴性预测因素。然而,多变量分析显示,只有BMI SDS、TG、HOMA - IR和APRI是NAFLD的阳性预测因素,女性为阴性预测因素。APRI作为NAFLD生化标志物的准确性约为60%。总之,在一个大型(意大利)儿科肥胖人群中,诸如BMI SDS、TG、HOMA - IR和APRI等参数是NAFLD的阳性预测因素,女性为阴性预测因素,且大部分预测可由APRI解释。然而,APRI似乎是肝损伤而非NAFLD/NASH的简单生化标志物,此外,其对NAFLD的预测/诊断准确性有限。